Harvard Bioscience expects its fiscal year 2026 performance growth will be strongly supported by a stable NIH funding environment and reduced tariff disruptions.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
El Niño disrupts palm oil: Indonesia and Malaysia's production expected to drop by 3% in 2027, price may rise towards $1226
Continuous drought caused by a strong El Niño is expected to reduce yields next year, and palm oil production in Indonesia and Malaysia is projected to decline by 2027, tightening global supply and pushing prices higher.
Lighter falls 11% after Bitwise’s LIT ETP launch – But there’s a catch!
To fit more HBM into chips, Nvidia accelerates advancement of glass substrate technology
German equipment manufacturer SCHMID has disclosed that it is collaborating with core firms in the supply chains of Intel, Nvidia, and AMD to develop glass substrate production equipment. Glass substrates are expected to replace silicon interposers, enhancing packaging density and data transmission capacity, and allowing for the integration of more HBMs. However, obstacles remain in the TGV metallization process, end-customer certification has not yet been completed, and large-scale commercialization will still take time.
Crypto prices
More
